Subscribe to the Daily PV Brief for breaking drug safety news, regulatory updates, and pharmacovigilance insights.
Daily News and Intelligence for the Pharmacovigilance Industry
Stay informed with timely coverage of drug safety, regulatory developments, safety signals, inspections, AI in pharmacovigilance, compliance trends, and career insights from across the global PV landscape.
Ramipril Recall After Packaging Error Raises Medication Mix-Up Risk
A precautionary recall of Ramipril 5 mg Capsules in the UK highlights how packaging errors can quickly become patient-safety events.
Today in PV
A quick scan of the latest stories, safety concerns, regulatory developments, and industry signals every pharmacovigilance professional should know today.
Explore Coverage
Browse the key areas shaping pharmacovigilance today, from global regulatory updates to safety signals, compliance trends, AI, and career growth.
Regulatory Updates
Track key developments from FDA, EMA, MHRA, WHO, NAFDAC, Health Canada, TGA, SAHPRA, and other health authorities.
Inspections & Compliance
Stay current on inspection readiness, CAPAs, SOP expectations, audit trends, and the compliance issues shaping PV systems.
Explainers
Clear, practical breakdowns of PV concepts, industry terms, reporting frameworks, and regulatory changes.
Careers
Insights for professionals building or advancing careers in pharmacovigilance, drug safety, compliance, and related functions.
Safety Signals
Follow emerging risks, label changes, recalls, medication errors, and other safety issues that matter in real-world pharmacovigilance.
AI & Digital PV
Explore how artificial intelligence, automation, and digital tools are influencing case processing, signal detection, and safety operations.
Latest News
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam. Aque ipsa quae ab illo inventore veritatis. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accus antium doloremque.
What PRAC Safety Signals Mean for Pharmacovigilance Teams
EMA publishes PRAC safety-signal recommendations each month. Here’s what they are, what they are not, and why PV teams should monitor them closely.
PAHO Calls for Stronger Pharmacovigilance After Reports of GLP-1 Misuse
PAHO has called for strengthened pharmacovigilance after reports of misuse involving GLP-1 medicines indicated for obesity in adults.
UK Clinical Trial Rules Change on 28 April 2026: What PV Teams Should Prepare For
Updated UK clinical trial regulations take effect on 28 April 2026. Here’s what pharmacovigilance and sponsor teams should know now.
FDA Launches AEMS: Why the New Adverse Event Monitoring System Matters for Pharmacovigilance
The FDA has launched the Adverse Event Monitoring System (AEMS), a new unified platform for adverse event reporting and analysis. Here’s what it means for pharmacovigilance professionals.
Featured Posts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Contact us
Email Us
editor@pvwatchdaily.com